Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/22/2022
China Biotech Firms Stunned by US Drug Trial U-Turn (Asia Financial)
3/21/2022
As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...
3/21/2022
Bavarian Nordic and Nuance Pharma Enter License for RSV Vaccine for ...
3/21/2022
China's Triastek and Siemens Strive to Accelerate Digital Transformati...
3/20/2022
FT: China Plans Audit Concession in Face of US Delisting Threat
3/18/2022
Lynk and Simcere Enter Strategic Commercialization Partnership in Chin...
3/18/2022
EdiGene Licenses from BCH the Methods and Compositions for Boosting Fe...
3/18/2022
Sinohealth: Chinese Public Hospital Drug Market Up 10.1% in 2021
3/18/2022
Drug R&D and Product Registration News Digest March 2022 (3)
3/18/2022
Recent Executive Moves
3/17/2022
Five Chinese Firms Agree to Make Generic Version of Pfizer's Oral COVI...
3/16/2022
Adagene, Merck Gets FDA Blessing P1b/2 Trial of ADG126/Keytruda Combo
3/16/2022
Pfizer COVID-19 Pill Added to Pandemic Treatment Guidelines in China ...
3/16/2022
China Resources Licenses Global Rights of Ab Studio's COVID Antibody ...
3/16/2022
PharmCube: An Analysis of NDAs in China
3/16/2022
Another Strike for Biotech: China (Evaluate)
3/15/2022
Biopharma Patents in China: Litigation, Licensing, and Patent Linkage ...
3/14/2022
China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)
3/14/2022
Chinese Investors' Interest In Cell And Gene Therapy Remains Strong
3/14/2022
CDE Releases the Draft Guidelines for Clinical Trial of Improvement Ch...
3/11/2022
Pharma CMO Stevanato Group Expands Capacity in China with New Facility
3/11/2022
NMPA Issues the List of Reference Formulations for GQCE Studies (52nd ...
3/11/2022
CDE Solicits Comments on the Draft Procedures for Adjustment of Publis...
3/11/2022
CDE Solicits Comments on the Draft Technical Guidelines for Protocol C...
3/11/2022
CDE Solicits Comments on Two Draft TCM Registration Guidelines
3/11/2022
Recent Executive Moves
3/11/2022
Drug R&D and Product Registration News Digest March 2022 (2)
3/10/2022
AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...
3/10/2022
SEC Sets Clock for Delisting Chinese Companies Over US Audit Demand (U...
3/10/2022
Zai Lab Revenue Triples, As It Struggles to Break Cycle of Mounting Lo...
Page:
169
/
797
Total number of articles:
23898
:
[First]
[<<]
[167]
[168]
[169]
[170]
[171]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit